VANCOUVER, BC, June 23, 2022 /PRNewswire/ – Numinus Wellness Inc. (“Numinus”, the “Firm”) (TSX: NUMI) (OTCQX: NUMIF), a psychological well being care firm advancing progressive remedies and secure, evidence-based psychedelic-assisted therapies, is happy to announce the launch of a Utah-based pilot program to assist companies enhance worker psychological well being by providing ketamine-assisted psychotherapy (KAP) as a well being profit for eligible workers (“Company KAP”).
Whereas Numinus’ Utah clinics, working below the Cedar Psychiatry model, have secured insurance coverage protection from choose insurance coverage firms for direct billing of ketamine for treatment-resistant despair, entry stays a problem for a lot of sufferers. To bridge this hole, Cedar Psychiatry and Utah-based HempLucid have been piloting Company KAP since 2019 to make sure that its workers with a psychological well being prognosis can entry the care they want. Per the association, HempLucid covers the price of ketamine infusions whereas leveraging its present healthcare insurance coverage plan to assist the remedy element of KAP.
“It has been revolutionary to how we function as a enterprise,” stated Chase Hudson, Founder and CEO of HempLucid. “Providing ketamine remedies to our workers has proven unimaginable advantages for therapeutic, positivity, and productiveness within the work atmosphere. We’re in a brand new period. A brand new social contract is being shaped between workers and employers, and companies are being pressured to check out the psychological well being of their workers. We’re working onerous to get out forward of it and deal with our folks in a proactive approach.”
With psychological sickness thought-about among the many highest cost-drivers for employers, investing in employees’ psychological well being is turning into a high precedence for enterprise leaders. Psychological sickness accounts for 70% of office incapacity prices.1 A research by Deloitte discovered that the median yearly return-on-investment of CAN$1.00 spent on psychological well being packages was CAN$2.18 amongst firms that had psychological well being initiatives in place for 3 or extra years.2 Company KAP is an progressive approach to assist employers enhance productiveness, decrease absenteeism and cut back incapacity prices by enhancing worker psychological well being.
Dr. Reid Robison, Chief Scientific Officer, Numinus, commented: “It is extra necessary than ever to deal with our particular person and collective psychological well being. This pilot expands entry to ketamine-assisted psychotherapy within the curiosity of not solely serving to people and households, but additionally a worldwide workforce that continues to report will increase in stress and burnout. It’s really inspiring to see an organization like HempLucid deal with workers on this approach.”
Numinus lately accomplished the acquisition of Novamind, which incorporates eight clinics in Utah working as Cedar Psychiatry and two clinics in Arizona working as Foundations for Change. Numinus is at the moment exploring how the Company KAP service providing could be expanded all through its 13 clinics throughout North America.
Numinus’ Cedar Psychiatry clinics supply sufferers entry to a variety of psychological well being companies, together with ketamine remedy, transcranial-magnetic stimulation (TMS), Spravato, speak remedy and medicine administration.
To find out about Company KAP for employers, go to: www.cedarpsychiatry.com/corporate-kap
To see a video concerning the Company KAP program being supplied at HempLucid, go to: https://youtu.be/RIu1axMAS7k.
Numinus Wellness (TSX: NUMI) helps folks to heal and be effectively by way of the event and supply of progressive psychological well being care and entry to secure, evidence-based psychedelic-assisted therapies. The Numinus mannequin – together with psychedelic analysis, manufacturing and clinic care – is on the forefront of a change geared toward therapeutic quite than managing signs for despair, anxiousness, trauma, ache and substance use. At Numinus, we’re main the combination of psychedelic-assisted therapies into mainstream medical observe and constructing the inspiration for a more healthy society.
Neither Numinus Wellness Inc., nor any of its subsidiaries is an expert company licensed to observe well being companies. In jurisdictions the place well being companies might solely be supplied by a company if that company holds a legitimate allow to take action, Numinus and its subsidiaries function in a administration companies perform to affiliated skilled companies, who present well being companies to sufferers. Numinus and its subsidiaries do present well being companies on to sufferers in these jurisdictions the place licensed to take action.
This information launch consists of sure “ahead‐trying data” and “ahead‐trying statements” (collectively “ahead‐trying statements”) throughout the which means of relevant Canadian securities laws, together with statements relating to the plans, intentions, beliefs and present expectations of the Firm with respect to future enterprise actions and working efficiency. All statements on this information launch that deal with occasions or developments that the Firm expects to happen sooner or later are ahead‐trying statements. Ahead‐trying statements are statements that aren’t historic details and are sometimes recognized by phrases corresponding to “count on”, “plan”, “anticipate”, “challenge”, “goal”, “potential”, “schedule”, “forecast”, “finances”, “estimate”, “intend” or “consider” and comparable expressions or their destructive connotations, or that occasions or situations “will”, “would”, “might”, “might”, “ought to” or “may” happen, and embrace data relating to expectations across the Company KAP, advantages and future plans relating thereto and availability of associated insurance coverage coverages; and expectation for different financial, enterprise and/or aggressive elements.
Ahead‐trying statements essentially contain assumptions, dangers and uncertainties, sure of that are past the Firm’s management. These ahead‐trying statements are certified of their entirety by cautionary statements and danger issue disclosure contained in filings made by the Firm with the Canadian securities regulators, together with the Firm’s monetary statements,associated MD&A and Annual Data Type for the monetary yr ended August 31, 2021 and its interim monetary statements and associated MD&A for the three and 6 months ended February 28, 2022, all filed with the securities regulatory authorities in all provinces and territories of Canada, besides Québec, and obtainable below the Firm’s profile at www.sedar.com. The danger elements aren’t exhaustive of the elements which will have an effect on the Firm’s ahead‐trying statements. The Firm’s ahead‐trying statements are based mostly on the relevant assumptions and elements administration considers cheap as of the date hereof, based mostly on the knowledge obtainable to administration of the Firm at such time. The Firm doesn’t assume any obligation to replace ahead‐trying statements if circumstances or administration’s beliefs, expectations or opinions ought to change aside from as required by relevant securities legal guidelines. There could be no assurance that ahead‐trying statements will show to be correct, and precise outcomes, efficiency or achievements might differ materially from these expressed in, or implied by, these ahead‐trying statements. Accordingly, undue reliance shouldn’t be positioned on ahead‐trying statements.
SOURCE Numinus Wellness Inc.